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Hormone Meat: more evidence of risks 
New evidence shows that the use of hormones to acceler-
ate growth in cattle is putting human health at risk. That is 
the opinion adopted by the Scientific Committee on 
Veterinary Measures relating to Public Health on 30 April. 
The Commission, whose duty it is to ensure a high level of 
protection for consumers, has therefore kept its ban on the 
import of meat containing hormones, but wants to continue 
the talks aimed at finding a compromise which will not 
reduce the flow of transatlantic trade. 
Committee opinion: the risks are real 
Six growth hormones used in meat production (17ß 
oestradiol, progesterone, testosterone, zeranol, tren-
bolone acetate and melengestrol acetate) may have 
endocrine, developmental, immunological, neurobio-
logical, immunotoxic, genotoxic and carcinogenic 
effects. The evidence is sufficient even though it 
varies in its conclusiveness and the available data do 
not allow a quantitative estimate of the risks. They 
are conceivable even at low doses, and a critical 
threshold cannot be established for any of the sub-
stances. Oestradiol-17ß, for example, has been iden-
tified as a complete carcinogen. Prepubertal children 
are most at risk from the substances. Those are the 
main conclusions contained in the opinion of the 
Scientific Committee* delivered after a thorough 
analysis of a wide range of scientific data, including 
very recent information. 
Seventeen scientific studies financed by the 
Commission on growth hormones are currently in 
progress. They are being carried out by independent 
scientists in various countries, including the Member 
States and the United States. The results are expected 
at the end of 2000. 
In addition, a report drawn up by Commission repre-
sentatives and independent experts has revealed a 
lack of controls which could permit the misuse of 
growth hormones contrary to the rules in force in the 
United States and Canada. This aggravates the risks 
which already exist of exposure to the substances. 
The ban stays... 
The Committee's conclusions have persuaded the 
Commission to maintain unchanged its ban on the 
import of hormone meat. Disputing the conclusions, 
the United States have asked the World Trade 
Organisation to authorise retaliatory measures worth 
202 million dollars unless the European Union ends 
the ban. WTO authorisation would allow the USA to 
impose 100% customs duties on European products, 
thus barring them from the American market. 
...but talks continue 
The European Union, encouraged in its desire to 
guarantee consumer safety by the new evidence from 
the Scientific Committee but wishing to honour its 
international trade commitments, is looking for a 
solution which is mutually beneficial and leads to the 
expansion of international trade rather than restrict-
ing it, so it is willing to further open up its market to 
American products for the time being. The United 
States have for their part accepted the European offer 
of talks between scientific experts. Thus, both sides 
have expressed their willingness to continue the dis-
cussion in order to arrive at a better understanding of 
the hormone problem. 
* Available on the internet: 
http://europa.eu.int/comm/dg24/health/sc/scv/index_en.html 
(From page 1 :) 
A decade of disputes 
As a reminder, the use of growth hormones and the 
import of meat treated with them have been banned 
in the Community since 1988. In contrast, the import 
of meat without hormones has never been banned. 
However, the Commission recently considered tem­
porarily suspending imports of American meat 
declared hormone-free unless checks were strength­
ened after hormone residues were found in 12% of 
samples analysed (see Newsletter No. 11). 
After a case brought by the United States and Canada 
against the ban on meat containing hormones, a WTO 
panel concluded that the ban was incompatible with 
the Agreement on the Application of Sanitary and 
Phytosanitary Measures (SPS Agreement) . The 
Commission appealed and on 13 February 1998 the 
WTO Appellate Body found partially in favour of the 
Commission in acknowledging the right of govern­
ments to guarantee their citizens, on a scientific 
basis, a level of protection greater than that provided 
by international rules. The Body stated that the argu­
ments raised need not coincide with prevailing scien­
tific opinion and that the level of risk need not nec­
essarily be quantifiable. 
On the other hand, the Appellate Body concluded that 
the Commission's arguments on growth hormones 
were not sufficiently specific on the harmfulness of 
residues of the hormones in meat. It added that the 
assessment of the risks may take account of improp­
er veterinary practices, abuses and control difficulties 
but that they had not been clearly assessed by the 
Commission. On 13 March 1998 the Commission 
declared its intention to carry out an additional 
assessment with a view to honouring its commit­
ments to the WTO. 
News in brief 
Agenda 2000/agrkulture formally adopted 
On 17 May the Council of agriculture ministers formally 
adopted the regulations proposed by the Commission to 
reform the CAP on the basis of the discussions at the 
Council meetings between 22 February and 11 March 
and the Berlin European Council of 24/25 March. An 
important decision was taken on the common market 
organisation (CMO) for milk: the mid-term review was 
kept at 2003, with the aim of ending the current milk 
quota scheme after 2006. For arable crops, a related mea­
sure already included in that CMO was reinserted in the 
regulation because the basic rate of compulsory set-aside 
was fixed at 10% for 2000-06 in Berlin, in place of the 
zero percent initially proposed by the Commission; this is 
because long-term set-aside land and land reforested 
under the rural development regulation can be accounted 
for as compulsory set-aside by farmers. The regulations 
can be found on the DG VI website indicated below. 
Tomatoes for processing: 1999-2000 quotas 
On 26 April the Commission adopted Regulation (EC) 
No 865/1999 which establishes the following allocation 
by Member State and product group of quotas for fresh 
tomatoes for processing for the 1999-2000 marketing 
year (in tonnes): 
Member 
Stute 
Greece 
Spain 
France 
Italy 
Portugal 
Total 
Tomato 
concentrate 
1 064 832 
696 663 
250 822 
1 771 812 
801 124 
4 S8S 253 
Preserved 
whole peeled 
tomatoes 
15619 
149 948 
32 502 
1113 528 
9 522 
1321 119 
Other 
products 
30 503 
158 219 
49324 
651 972 
39 872 
929 890 
Total 
1 110 954 
1 004 830 
332 648 
3 537 312 
850 518 
6 836 262 
The allocation is based on the average quantities pro­
duced in the previous two marketing years for which the 
minimum price was paid. From the current year onward 
quotas per Member State and product group may not vary 
by more than 10% from one year to the next. 
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